Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Market Cap	1.37B -60.3%
Revenue (ttm)	5.74B -7.8%
Net Income	-3.62B
EPS	n/a
Shares Out	1.11B
PE Ratio	n/a
Forward PE	16.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,304,600
Average Volume	12,135,010
Open	1.180
Previous Close	1.230
Day's Range	1.090 - 1.340
52-Week Range	1.110 - 6.710
Beta	1.11
RSI	37.69
Earnings Date	Mar 30, 2026

About BVMF:ONCO3

Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, chemotherapy, oral chemotherapy, and prostate cancer hormone therapy; and surgery procedures, such as breast, head and neck, lung, prostate cancer, stoma...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2010
• Country: Brazil
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: ONCO3

Financial Performance

In 2025, BVMF:ONCO3's revenue was 5.74 billion, a decrease of -7.83% compared to the previous year's 6.23 billion. Losses were -3.62 billion, 460.8% more than in 2024.